Related references
Note: Only part of the references are listed.A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer
Ian S. Reynolds et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2017)
Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease
Jordan Axelrad et al.
CLINICAL COLORECTAL CANCER (2017)
Immune Checkpoint Inhibitors in Challenging Populations
Douglas B. Johnson et al.
CANCER (2017)
Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management
Parambir S. Dulai et al.
CANCER PREVENTION RESEARCH (2016)
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
Douglas B. Johnson et al.
JAMA ONCOLOGY (2016)
Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada
Eric I. Benchimol et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature
Dana Duricova et al.
JOURNAL OF CROHNS & COLITIS (2014)
Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis
Eun Ran Kim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010
Tine Jess et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-analysis of Population-based Cohort Studies
Maurice W. M. D. Lutgens et al.
INFLAMMATORY BOWEL DISEASES (2013)
Clinical Outcome of IBD-Associated versus Sporadic Colorectal Cancer: A Matched-Pair Analysis
Bernhard W. Renz et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Outcomes From IBD-Associated and Non-IBD-Associated Colorectal Cancer: A Surveillance Epidemiology and End Results Medicare Study
Susan L. Gearhart et al.
DISEASES OF THE COLON & RECTUM (2012)
Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk?
Jessica K. Dyson et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
5-Aminosalicylate Is Not Chemoprophylactic for Colorectal Cancer in IBD: A Population Based Study
Charles N. Bernstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Intestinal Inflammation and Cancer
Thomas A. Ullman et al.
GASTROENTEROLOGY (2011)
Widespread But Not Localized Neoplasia in Inflammatory Bowel Disease Worsens the Prognosis of Colorectal Cancer
Stephan Brackmann et al.
INFLAMMATORY BOWEL DISEASES (2010)
Ulcerative Colitis and Cancer
Mahmoud N. Kulaylat et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data
E. I. Benchimol et al.
GUT (2009)
Two Distinct Groups of Colorectal Cancer in Inflammatory Bowel Disease
Stephan Brackmann et al.
INFLAMMATORY BOWEL DISEASES (2009)
Long-term prognosis in Crohn's disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff
C. Canavan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Colorectal cancer prognosis among patients with inflammatory bowel disease
T Delaunoit et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies
FS Velayos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Survival and cause-specific mortality in ulcerative colitis: Follow-up of a population-based cohort in Copenhagen county
KV Winther et al.
GASTROENTEROLOGY (2003)
Colorectal cancer complicating Crohn's disease
HJ Freeman
CANADIAN JOURNAL OF GASTROENTEROLOGY (2001)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
Share Paper
